Evaluation of Visual Acuity and Patient Satisfaction With AT LISA TRI 839MP Intraocular Lenses
Sponsored by Carl Zeiss Meditec AG
About this trial
Last updated 7 years ago
Study ID
839 MP HEN 402-11
Status
Completed
Type
Interventional
Phase
N/A
Placebo
No
Accepting
50+ Years
All
Trial Timing
Ended 12 years ago
What is this trial about?
The purpose of the study is to evaluate the far, intermediate and near visual acuities
with a trifocal IOL.
What are the participation requirements?
Inclusion Criteria
- Man or woman, over 50 years of age
- Bilateral implantation of a trifocal intraocular lens
- Capsular bag implantation
Exclusion Criteria
- Existing ocular pathology
- Surgical complications
- Corneal astigmatism ≥ 1.0D